TPX2 and non-small cell lung carcinoma: Subsequently, we used in vitro functional assays to silence the prognostic TPX2 biomarker gene in NSCLC A549 cells and found that the proliferation and migration ability of A549 cells were significantly reduced, which further confirmed that the NSCLC-related biomarkers screened by the machine learning approach are novel and reliable.